| Title |
Inhaled corticosteroids versus long-acting beta<sub>2</sub>-agonists for chronic obstructive pulmonary disease
|
|---|---|
| Published by |
John Wiley & Sons, Ltd, December 2011
|
| DOI | 10.1002/14651858.cd007033.pub3 |
| Pubmed ID | |
| Authors |
Spencer, Sally, Karner, Charlotta, Cates, Christopher J, Evans, David J |
| Abstract |
Long-acting beta(2)-agonists and inhaled corticosteroids can be used as maintenance therapy by patients with moderate to severe chronic obstructive pulmonary disease. These interventions are often taken together in a combination inhaler. However, the relative added value of the two individual components is unclear. |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 20% |
| Unknown | 8 | 80% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 10 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 122 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Colombia | 1 | <1% |
| Unknown | 120 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 17 | 14% |
| Researcher | 14 | 11% |
| Other | 11 | 9% |
| Student > Bachelor | 11 | 9% |
| Student > Doctoral Student | 9 | 7% |
| Other | 21 | 17% |
| Unknown | 39 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 56 | 46% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
| Nursing and Health Professions | 5 | 4% |
| Agricultural and Biological Sciences | 3 | 2% |
| Psychology | 3 | 2% |
| Other | 6 | 5% |
| Unknown | 44 | 36% |